Rogers, O. C.
Rosen, D. M.
Antony, L.
Harper, H. M.
Das, D.
Yang, X.
Minn, I.
Mease, R. C.
Pomper, M. G.
Denmeade, S. R.
Funding for this research was provided by:
NIH (P30CA006973)
U.S. Department of Defense (W81XWH-15-1-0382)
Article History
Received: 12 April 2021
Accepted: 16 June 2021
First Online: 21 July 2021
Competing interests
: MGP received Grants and other from Progenics Pharmaceuticals as well as holding a patent (US 8,778,305 B2) covering the small molecule PSMA inhibitor 18F-DCFPyL with royalties paid (Progenics Pharmaceuticals). Remaining authors declare no conflict of interest.